Abstract
Atrial fibrillation is one of the main risk factor of ischemic stroke. Current problems of the management of patients with stroke due to non-valvular atrial fibrillation and secondary stroke prevention in these patients are considered. Data of own author's observation for patients of this type during 6 months after discharge from the hospital are presented. The problems which patients faced with are analyzed. Comparative assessment of warfarin and dabigatran therapies is given.
Cite
CITATION STYLE
Drozdova, E. A. (2014). SECONDARY PREVENTION OF STROKE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: THE CLINICIANS’ VIEWPOINT. Rational Pharmacotherapy in Cardiology, 10(2), 179–183. https://doi.org/10.20996/1819-6446-2014-10-2-179-183
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.